GTO ID | GTD0334 |
Accession | E-MTAB-11315 |
Gene therapy-related clinical trial | GTC2404 |
Altered gene | S |
Gene xrefs |
Gene ID:
1489668
|
Treatment | ARCT-021(ARCT COVID-19 vaccine) |
Control | Click to openARCT.101.1102.Day3_07;ARCT.101.1107.Day3_12;ARCT.101.2103.Day3_09;ARCT.101.2106.Day3_06;ARCT.101.2108.Day3_03;ARCT.101.2111.Day3_03;ARCT.101.3101.Day3_03;ARCT.101.3104.Day3_12;ARCT.101.4103.Day3_11;ARCT.101.4107.Day3_03;ARCT.101.4117.Day3_01;ARCT.101.4119.Day3_07;ARCT.101.5104.Day3_08;ARCT.101.5108.Day3_12;ARCT.101.5109.Day3_01;ARCT.101.5116.Day3_08;ARCT.101.6103.Day3_11;ARCT.101.6108.Day3_07;ARCT.101.6110.Day3_03;ARCT.101.6111.Day3_07;ARCT.101.7103.Day3_05;ARCT.101.7105.Day3_11;ARCT.101.7108.Day3_03;ARCT.101.7115.Day3_07;ARCT.101.8105.Day3_05;ARCT.101.8106.Day3_09;ARCT.101.8109.Day3_09;ARCT.101.8112.Day3_09 |
Case | Click to openARCT.101.3102.Day3_06;ARCT.101.3103.Day3_09;ARCT.101.3105.Day3_03;ARCT.101.3106.Day3_06;ARCT.101.3107.Day3_09 |
Disease | COVID-19 |
Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
Organism | Homo sapiens |
Tissue/Cell type | blood |
Characteristics | Day3;10 microgram |
Strategy | Microarray |
Platform | A-MTAB-668 |